These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 15719481)

  • 1. PLGA nanoparticles in drug delivery: the state of the art.
    Bala I; Hariharan S; Kumar MN
    Crit Rev Ther Drug Carrier Syst; 2004; 21(5):387-422. PubMed ID: 15719481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.
    Avgoustakis K
    Curr Drug Deliv; 2004 Oct; 1(4):321-33. PubMed ID: 16305394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cryoprotectants on the reconstitution of surfactant-free nanoparticles of poly(DL-lactide-co-glycolide).
    Jeong YI; Shim YH; Kim C; Lim GT; Choi KC; Yoon C
    J Microencapsul; 2005 Sep; 22(6):593-601. PubMed ID: 16401576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-loaded PLGA nanoparticles for oral administration: fundamental issues and challenges ahead.
    Kumar G; Shafiq N; Malhotra S
    Crit Rev Ther Drug Carrier Syst; 2012; 29(2):149-82. PubMed ID: 22475089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential use of polymeric nanoparticles for drug delivery across the blood-brain barrier.
    Tosi G; Bortot B; Ruozi B; Dolcetta D; Vandelli MA; Forni F; Severini GM
    Curr Med Chem; 2013; 20(17):2212-25. PubMed ID: 23458620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and characterisation of new nanoparticulate polymer blends for drug delivery.
    Csaba N; González L; Sánchez A; Alonso MJ
    J Biomater Sci Polym Ed; 2004; 15(9):1137-51. PubMed ID: 15503631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles made of fluorescence-labelled Poly(L-lactide-co-glycolide): preparation, stability, and biocompatibility.
    Weiss B; Schaefer UF; Zapp J; Lamprecht A; Stallmach A; Lehr CM
    J Nanosci Nanotechnol; 2006; 6(9-10):3048-56. PubMed ID: 17048517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of cationic PLGA nanospheres as DNA carriers.
    Ravi Kumar MN; Bakowsky U; Lehr CM
    Biomaterials; 2004 May; 25(10):1771-7. PubMed ID: 14738840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs.
    Saez A; Guzmán M; Molpeceres J; Aberturas MR
    Eur J Pharm Biopharm; 2000 Nov; 50(3):379-87. PubMed ID: 11072195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip.
    Grayson AC; Voskerician G; Lynn A; Anderson JM; Cima MJ; Langer R
    J Biomater Sci Polym Ed; 2004; 15(10):1281-304. PubMed ID: 15559850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLGA-based nanoparticles as cancer drug delivery systems.
    Sadat Tabatabaei Mirakabad F; Nejati-Koshki K; Akbarzadeh A; Yamchi MR; Milani M; Zarghami N; Zeighamian V; Rahimzadeh A; Alimohammadi S; Hanifehpour Y; Joo SW
    Asian Pac J Cancer Prev; 2014; 15(2):517-35. PubMed ID: 24568455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propaedeutic study for the delivery of nucleic acid-based molecules from PLGA microparticles and stearic acid nanoparticles.
    Grassi G; Coceani N; Farra R; Dapas B; Racchi G; Fiotti N; Pascotto A; Rehimers B; Guarnieri G; Grassi M
    Int J Nanomedicine; 2006; 1(4):523-33. PubMed ID: 17722283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
    Jain RA
    Biomaterials; 2000 Dec; 21(23):2475-90. PubMed ID: 11055295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyelectrolyte coated polymeric nanoparticles for controlled release of docetaxel.
    Agrawal R; Shanavas A; Yadav S; Aslam M; Bahadur D; Srivastava R
    J Biomed Nanotechnol; 2012 Feb; 8(1):19-28. PubMed ID: 22515091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent applications of PLGA based nanostructures in drug delivery.
    Mir M; Ahmed N; Rehman AU
    Colloids Surf B Biointerfaces; 2017 Nov; 159():217-231. PubMed ID: 28797972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
    Li X; Xu Y; Chen G; Wei P; Ping Q
    Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrasound-induced degradation of PLA and PLGA during microsphere processing: influence of formulation variables.
    Reich G
    Eur J Pharm Biopharm; 1998 Mar; 45(2):165-71. PubMed ID: 9704913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics.
    Jain AK; Das M; Swarnakar NK; Jain S
    Crit Rev Ther Drug Carrier Syst; 2011; 28(1):1-45. PubMed ID: 21395514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.